Coronavirus / COVID

Discussing the link between risk of death from SARS-CoV-2 and levels of Omega-3.

Adverse cardiac phenotypes are associated with greater odds of contracting the virus.

The data additionally show a 94% prevention against asymptomatic SARS-CoV-2 infection, at a time when the country's dominant strain was the B.1.1.7 variant.

France announces a relaxation on restrictions involving international travel outside the EU.

This Emergency Use Listing (EUL) of this single-shot vaccine opens up the door to much of the developing world to gain access to it.

Though the product is authorized more than 70 countries, there is currently no reported US trial data, nor application for authorization to the FDA.

Strong immunologic responses to vaccination for SARS-CoV-2 in COVID-19 survivors suggest that first of 2-dose vaccination could suffice.

The investigational candidate has shown to be 55% and 86.3% effective respectively.

The analysis highlights the importance of high-frequency testing as a complement to social distancing, vaccination, and other mitigation strategies.

Managing mental health in adults living with HIV is paramount during the COVID-19 pandemic.

The acquisition of the Johnson & Johnson pharmaceutical company's vaccine would likely be completed in the latter half of this year.

Plasma proteome confirmed the association between cellular and humoral SARS-CoV-2 immunity.

Johns Hopkins data suggest men are being hospitalized more frequently with infection, and are facing more severe outcomes.

MN titers showed a striking increase after just 1 dose in experienced subjects.

Convalescent plasma treatment was found not to improve survival or disease course in the patient group.

A UK health authority representative discussed the possibility of a fall season booster to prevent another winter surge of cases.

Gut microbiome is known to release enzymes that degrade plasma glycans which regulate inflammation.

Increased hospitalization risk was driven mainly by the high burden of comorbidities in both groups.

Though small in scale and still cautious, the new advisory reflects confidence in SARS-CoV-2 mitigation among a more vaccinated population.

Investigators examined outcomes of privileged US citizens and compared them to those health outcomes of average residents in other developed countries.

Windtree Therapeutics is in a phase 2 clinical trial for its investigational therapy, Lucinactant, which produces a synthetic surfactant being studied for acute lung injury in patients with COVID-19 and acute respiratory distress syndrome (ARDS).

A discussion on the pros and cons of frequent, rapid testing in the community.

Cue Health's test is over the counter (OTC) and can be utilized at home.

Hyper-induction of pro-inflammatory cytokines is one of the key aspects of SARS-CoV-2.

Molecular tools like RNA-activated RNases could be a potential new paradigm for therapeutics.